Aims: The manner in which hydrogen sulfide (H2S) suppresses neuroinflammation is poorly understood. We investigated whether H2S polarized microglia to an anti-inflammatory (M2) phenotype by activating AMP-activated protein kinase (AMPK). Results: Three structurally unrelated H2S donors (5-(4-hydroxyphenyl)-3H-1,2-dithiocyclopentene-3-thione [ADT-OH], (p-methoxyphenyl) morpholino-phosphinodithioic acid [GYY4137], and sodium hydrosulfide [NaHS]) enhanced AMPK activation in BV2 microglial cells in the presence and absence of lipopolysaccharide (LPS). The overexpression of the H2S synthase cystathionine β-synthase (CBS) in BV2 cells enhanced endogenous H2S production and AMPK activation regardless of LPS stimulation. On LPS stimulation, overexpression of both ADT-OH and CBS promoted M2 polarization of BV2 cells, as evidenced by suppressed M1 and elevated M2 signature gene expression. The promoting effects of ADT-OH on M2 polarization were attenuated by an AMPK inhibitor or AMPK knockdown. Liver kinase B1 (LKB1) and calmodulin-dependent protein kinase kinase β (CaMKKβ) are upstream kinases that activate AMPK. ADT-OH activated AMPK in Hela cells lacking LKB1. In contrast, both the CaMKKβ inhibitor and siRNA abolished ADT-OH activation of AMPK in LPS-stimulated BV2 cells. Moreover, the CaMKKβ inhibitor and siRNA blunted ADT-OH suppression on M1 gene expression and enhancement of M2 gene expression in LPS-stimulated BV2 cells. Moreover, ADT-OH promoted M2 polarization of primary microglia in an AMPK activation- and CaMKKβ-dependent manner. Finally, in an LPS-induced in vivo neuroinflammation model, both ADT-OH and NaHS enhanced AMPK activation in the brain area where microglia were over-activated on LPS stimulation. Furthermore, ADT-OH suppressed M1 and promoted M2 gene expression in this in vivo model. Innovation and Conclusion: CaMKKβ-dependent AMPK activation is an unrecognized mechanism underlying H2S suppression on neuroinflammation. Antioxid. Redox Signal. 21, 1741–1758.
Get full access to this article
View all access options for this article.
References
1.
AbeK and KimuraH. The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci, 16: 1066–1071, 1996.
2.
Abou-MohamedG, JohnsonJA, JinL, El-RemessyAB, DoK, KaesemeyerWH, CaldwellRB, and CaldwellRW. Roles of superoxide, peroxynitrite, and protein kinase C in the development of tolerance to nitroglycerin. J Pharmacol Exp Ther, 308: 289–299, 2004.
BaiA, MaAG, YongM, WeissCR, MaY, GuanQ, BernsteinCN, and PengZ. Ampk agonist downregulates innate and adaptive immune responses in tnbs-induced murine acute and relapsing colitis. Biochem Pharmacol, 80: 1708–1717, 2010.
5.
ChiY, LiK, YanQ, KoizumiS, ShiL, TakahashiS, ZhuY, MatsueH, TakedaM, KitamuraM, and YaoJ. Nonsteroidal anti-inflammatory drug flufenamic acid is a potent activator of amp-activated protein kinase. J Pharmacol Exp Ther, 339: 257–266, 2011.
6.
CortonJM, GillespieJG, HawleySA, and HardieDG. 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating amp-activated protein kinase in intact cells?. Eur J Biochem, 229: 558–565, 1995.
7.
CraftJM, WattersonDM, and Van EldikLJ. Neuroinflammation: a potential therapeutic target. Expert Opin Ther Targets, 9: 887–900, 2005.
8.
DavidS and KronerA. Repertoire of microglial and macrophage responses after spinal cord injury. Nat Rev Neurosci, 12: 388–399, 2011.
9.
GiordanettoF and KarisD. Direct amp-activated protein kinase activators: a review of evidence from the patent literature. Expert Opin Ther Pat, 22: 1467–1477, 2012.
10.
GongQH, WangQ, PanLL, LiuXH, HuangH, and ZhuYZ. Hydrogen sulfide attenuates lipopolysaccharide-induced cognitive impairment: a pro-inflammatory pathway in rats. Pharmacol Biochem Behav, 96: 52–58, 2010.
11.
GoranssonO, McBrideA, HawleySA, RossFA, ShpiroN, ForetzM, ViolletB, HardieDG, and SakamotoK. Mechanism of action of a-769662, a valuable tool for activation of amp-activated protein kinase. J Biol Chem, 282: 32549–32560, 2007.
12.
GreenMF, AndersonKA, and MeansAR. Characterization of the camkkbeta-ampk signaling complex. Cell Signal, 23: 2005–2012, 2011.
HawleySA, BoudeauJ, ReidJL, MustardKJ, UddL, MakelaTP, AlessiDR, and HardieDG. Complexes between the lkb1 tumor suppressor, strad alpha/beta and mo25 alpha/beta are upstream kinases in the amp-activated protein kinase cascade. J Biol, 2: 28, 2003.
15.
HawleySA, FullertonMD, RossFA, SchertzerJD, ChevtzoffC, WalkerKJ, PeggieMW, ZibrovaD, GreenKA, MustardKJ, KempBE, SakamotoK, SteinbergGR, and HardieDG. The ancient drug salicylate directly activates amp-activated protein kinase. Science, 336: 918–922, 2012.
16.
HuLF, LuM, Hon WongPT, and BianJS. Hydrogen sulfide: neurophysiology and neuropathology. Antioxid Redox Signal, 15: 405–419, 2011.
17.
HuLF, WongPT, MoorePK, and BianJS. Hydrogen sulfide attenuates lipopolysaccharide-induced inflammation by inhibition of p38 mitogen-activated protein kinase in microglia. J Neurochem, 100: 1121–1128, 2007.
18.
HuX, LiP, GuoY, WangH, LeakRK, ChenS, GaoY, and ChenJ. Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke, 43: 3063–3070, 2012.
19.
JiaJ, XiaoY, WangW, QingL, XuY, SongH, ZhenX, AoG, AlkayedNJ, and ChengJ. Differential mechanisms underlying neuroprotection of hydrogen sulfide donors against oxidative stress. Neurochem Int, 62: 1072–1078, 2013.
20.
KigerlKA, GenselJC, AnkenyDP, AlexanderJK, DonnellyDJ, and PopovichPG. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci, 29: 13435–13444, 2009.
21.
KimuraY, DarguschR, SchubertD, and KimuraH. Hydrogen sulfide protects ht22 neuronal cells from oxidative stress. Antioxid Redox Signal, 8: 661–670, 2006.
22.
LabuzekK, LiberS, GabryelB, AdamczykJ, and OkopienB. Metformin increases phagocytosis and acidifies lysosomal/endosomal compartments in ampk-dependent manner in rat primary microglia. Naunyn Schmiedebergs Arch Pharmacol, 381: 171–186, 2010.
23.
LeeHJ, MariappanMM, FeliersD, CavaglieriRC, SataranatarajanK, AbboudHE, ChoudhuryGG, and KasinathBS. Hydrogen sulfide inhibits high glucose-induced matrix protein synthesis by activating amp-activated protein kinase in renal epithelial cells. J Biol Chem, 287: 4451–4461, 2012.
24.
LeeM, SparatoreA, Del SoldatoP, McGeerE, and McGeerPL. Hydrogen sulfide-releasing nsaids attenuate neuroinflammation induced by microglial and astrocytic activation. Glia, 58: 103–113, 2010.
25.
LeeSK, LeeJO, KimJH, KimN, YouGY, MoonJW, ShaJ, KimSJ, LeeYW, KangHJ, ParkSH, and KimHS. Coenzyme q10 increases the fatty acid oxidation through ampk-mediated pparalpha induction in 3t3-l1 preadipocytes. Cell Signal, 24: 2329–2336, 2012.
26.
LiuYY, SparatoreA, Del SoldatoP, and BianJS. Acs84, a novel hydrogen sulfide-releasing compound, protects against amyloid beta-induced cell cytotoxicity. Neurochem Int, 58: 591–598, 2011.
27.
LuDY, TangCH, ChenYH, and WeiIH. Berberine suppresses neuroinflammatory responses through amp-activated protein kinase activation in bv-2 microglia. J Cell Biochem, 110: 697–705, 2010.
28.
MannaP and JainSK. L-cysteine and hydrogen sulfide increase pip3 and ampk/ppargamma expression and decrease ros and vascular inflammation markers in high glucose treated human u937 monocytes. J Cell Biochem, 114: 2334–2345, 2013.
29.
MantovaniA, BiswasSK, GaldieroMR, SicaA, and LocatiM. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol, 229: 176–185, 2013.
30.
MartelliA, TestaiL, BreschiMC, BlandizziC, VirdisA, TaddeiS, and CalderoneV. Hydrogen sulphide: novel opportunity for drug discovery. Med Res Rev, 32: 1093–1130, 2010.
31.
MarutaniE, KosugiS, TokudaK, KhatriA, NguyenR, AtochinDN, KidaK, Van LeyenK, AraiK, and IchinoseF. A novel hydrogen sulfide-releasing n-methyl-d-aspartate receptor antagonist prevents ischemic neuronal death. J Biol Chem, 287: 32124–32135, 2012.
32.
MorikawaT, KajimuraM, NakamuraT, HishikiT, NakanishiT, YukutakeY, NagahataY, IshikawaM, HattoriK, TakenouchiT, TakahashiT, IshiiI, MatsubaraK, KabeY, UchiyamaS, NagataE, GadallaMM, SnyderSH, and SuematsuM. Hypoxic regulation of the cerebral microcirculation is mediated by a carbon monoxide-sensitive hydrogen sulfide pathway. Proc Natl Acad Sci U S A, 109: 1293–1298, 2012.
33.
NathN, GiriS, PrasadR, SalemML, SinghAK, and SinghI. 5-aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis. J Immunol, 175: 566–574, 2005.
34.
NathN, KhanM, PaintliaMK, SinghI, HodaMN, and GiriS. Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis. J Immunol, 182: 8005–8014, 2009.
35.
O'NeillLA and HardieDG. Metabolism of inflammation limited by ampk and pseudo-starvation. Nature, 493: 346–355, 2013.
36.
OwenMR, DoranE, and HalestrapAP. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J, 348Pt 3: 607–614, 2000.
37.
RacioppiL and MeansAR. Calcium/calmodulin-dependent protein kinase kinase 2: roles in signaling and pathophysiology. J Biol Chem, 287: 31658–31665, 2012.
RussoGL, RussoM, and UngaroP. Amp-activated protein kinase: a target for old drugs against diabetes and cancer. Biochem Pharmacol, 86: 339–350, 2013.
40.
SagD, CarlingD, StoutRD, and SuttlesJ. Adenosine 5′-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J Immunol, 181: 8633–8641, 2008.
41.
ShawRJ, LamiaKA, VasquezD, KooSH, BardeesyN, DepinhoRA, MontminyM, and CantleyLC. The kinase lkb1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science, 310: 1642–1646, 2005.
42.
ShibuyaN, TanakaM, YoshidaM, OgasawaraY, TogawaT, IshiiK, and KimuraH. 3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain. Antioxid Redox Signal, 11: 703–714, 2009b.
43.
This reference has been deleted.
44.
SzabóC. Hydrogen sulphide and its therapeutic potential. Nat. Rev.Drug Discov, 6: 917–935, 2007.
45.
TiainenM, YlikorkalaA, and MäkeläTP. Growth suppression by Lkb1 is mediated by a G1 cell cycle arrest. PNAS, 96: 9248–9251, 1999.
46.
WangR. Physiological implications of hydrogen sulfide: a whiff exploration that blossomed. Physiol Rev, 92: 791–896, 2012.
47.
WenYD, WangH, KhoSH, RinkikoS, ShengX, ShenHM, and ZhuYZ. Hydrogen sulfide protects huvecs against hydrogen peroxide induced mitochondrial dysfunction and oxidative stress. PLoS One, 8: e53147, 2013.
48.
WhitemanM, LiL, RoseP, TanCH, ParkinsonDB, and MoorePK. The effect of hydrogen sulfide donors on lipopolysaccharide-induced formation of inflammatory mediators in macrophages. Antioxid Redox Signal, 12: 1147–1154, 2010.
49.
WiliñskiB, WiliñskiJ, SomogyiE, PiotrowskaJ, and OpokaW. Metformin raises hydrogen sulfide tissue concentrations in various mouse organs. Pharmacol Rep, 65: 737–742, 2013.
50.
XueR, HaoDD, SunJP, LiWW, ZhaoMM, LiXH, ChenY, ZhuJH, DingYJ, JunLiu, and ZhuYC. Hydrogen sulfide treatment promotes glucose uptake by increasing insulin receptor sensitivity and ameliorates kidney lesions in type 2 diabetes. Antioxid Redox Signal, 19: 5–23, 2013.
51.
ZhangY and YeJ. Mitochondrial inhibitor as a new class of insulin sensitizer. Acta Pharm Sin B, 2: 341–349, 2012.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
